0001209191-15-048129.txt : 20150529 0001209191-15-048129.hdr.sgml : 20150529 20150529211021 ACCESSION NUMBER: 0001209191-15-048129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150528 FILED AS OF DATE: 20150529 DATE AS OF CHANGE: 20150529 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHAPLIN DAVID CENTRAL INDEX KEY: 0001167232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 15901100 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-28 0 0000908259 OXIGENE INC OXGN 0001167232 CHAPLIN DAVID C/O OXIGENE, INC. 701 GATEWAY BLVD, SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Scientific Officer Employee Stock Option (Right to Buy) 1.43 2015-05-28 4 A 0 225000 0.00 A 2025-05-28 Common Stock 225000 225000 D Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), pursuant to the OXiGENE, Inc. 2015 Equity Incentive Plan, as partial compensation for his services as Chief Scientific Officer. 25% of the Stock Options vest immediately, and the remainder will vest in 36 substantially equal monthly installments beginning on the one month anniversary of the grant date. /s/ Megan N. Gates, attorney-in-fact 2015-05-29